Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FCQ1A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,660
Award facts
- Contract value 100% obligated
- $15,659.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,659.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen auto-injectors on November 18, 2025, with a completion date of November 19, 2025. This non-competitive, non-set-aside delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. Dupixent (dupilumab) is a biologic medication primarily used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and moderate-to-severe asthma, making it a specialized pharmaceutical product within the Defense Health Agency's medical supply requirements.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle valued through December 2026 that serves as a global pharmaceutical support mechanism for military healthcare programs. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains in support of military, veteran, and coast guard healthcare systems. The company's consistent receipt of competitively awarded delivery orders demonstrates its established capability to meet federal procurement standards for specialized pharmaceutical products.
Quick answers
Who was awarded contract SPE2DR26FCQ1A?
SPE2DR26FCQ1A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FCQ1A worth?
The government has obligated $15,660 on SPE2DR26FCQ1A.
Is contract SPE2DR26FCQ1A an order under another contract?
Yes. SPE2DR26FCQ1A is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCQ1A competed?
The extent of competition for SPE2DR26FCQ1A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award